Navigation Links
Abbott Receives FDA Clearance for New CELL-DYN(R) Emerald(TM) Hematology Instrument

ABBOTT PARK, Ill., Feb. 11 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new, compact hematology instrument, CELL-DYN Emerald(TM). Abbott's CELL-DYN Emerald will expand the company's hematology platform by offering a high performance, affordable solution for small to mid- sized clinical laboratories.

As small to mid-sized hospital laboratories and clinics continue to seek greater efficiency and productivity under tighter space limitations, Emerald's small size, touch screen software, and reliability offer an easy-to-use, compact table/bench top instrument for performing complete blood counts (CBCs), a test routinely ordered by doctors to assess a patient's overall health and to screen for a variety of disorders such as anemia and infection.

This new hematology system has many automation features designed to save laboratories' time, allowing them to improve productivity and reduce costs. Time saving features of Abbott's CELL-DYN Emerald include:

    -- A full touch-screen monitor to simplify operation.
    -- One-button startup.
    -- Low reagent consumption.
    -- Automatic cleaning and shutdown features.
    -- Barcode labeled reagents.

A key facet of CELL-DYN Emerald is its compact size -- weighing just 9kg (< 20 lbs) -- as well as its intuitive software interface that allows for easy navigation and quick results. With Abbott's Emerald, CBC results are completed in 60 seconds and reported in an easy-to-read format with histograms representing white blood cells, red blood cells and platelets.

"As hospitals and clinics try to do more, faster and in less space, Abbott's CELL-DYN Emerald offers a compact, fast, reliable analyzer to support the hematology testing needs of many small to medium-sized hospital laboratories and clinics," said Mike Warmuth, senior vice president, diagnostics, Abbott.


Abbott's CELL-DYN Emerald joins the company's full line of automated hematology instruments including: CELL-DYN Sapphire(R), CELL-DYN Ruby(R), CELL-DYN(R) 3700, CELL-DYN(R) 3200 and CELL-DYN(R) 1800.

Abbott's CELL-DYN instruments are well known for their efficiency and ability to provide fast access to patient results. Instruments range from larger analyzers that process a high number of patient samples to smaller instruments designed for medium and small-volume facilities.

Besides supplying standard CBC results, some instruments have additional features to aid in the evaluation of more complex disease states or infections including cancer, HIV and a variety of anemias.

About Abbott's Diagnostics Businesses

Abbott is a global leader in in vitro diagnostics and offers a broad range of innovative instrument systems and tests for hospitals, reference labs, molecular labs, blood banks, physician offices and clinics. With more than 65,000 institutional customers in more than 100 countries, Abbott's diagnostic products offer customers automation, convenience, bedside testing, cost effectiveness and flexibility. Abbott has helped transform the practice of medical diagnosis from an art to a science through the company's commitment to improving patient care and lowering costs. The history of Abbott is filled with examples of first-of-a-kind diagnostic products and significant technological and research advancements.

About Abbott

Abbott is a global, broad-based health care company devoted to the discovery, development, manufacture and marketing of pharmaceuticals and medical products, including nutritionals, devices and diagnostics. The company employs approximately 69,000 people and markets its products in more than 130 countries.

Abbott's news releases and other information are available on the company's Web site at

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Abbott to Present at Bear Stearns Healthcare Conference
2. The National Center for Missing & Exploited Children, Wal-Mart, and Abbott Host Child Safety Events
3. Dow Jones Sustainability Index Again Recognizes Abbott for Continued Leadership in Business, Environmental and Social Performance
4. Abbott Declares 335th Consecutive Quarterly Dividend
5. Abbott Again Honored as Top Company for Working Moms
6. Abbotts HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize for Innovation in Patient Care
7. Abbott Hosts Conference Call for Third-Quarter Earnings
8. Abbott Broadens Use of i-STAT Handheld Blood Analyzer with CLIA Waiver Granted by FDA for CHEM8+ Test Cartridge
9. Abbott Named One of the Best Companies for Hispanics by Hispanic Business Magazine
10. Abbott Again Honored as a Leader in Diversity
11. Abbott Researchers Target Neuronal Nicotinic Receptors for Treatment of Pain and Cognition
Post Your Comments:
(Date:10/10/2015)... ... ... walk with crutches for the rest of my life," said an inventor from San Diego, ... give me more independence and freedom would be amazing. This inspired me to invent a ... STRAP IN to enable an individual to walk with crutches without having to use his ...
(Date:10/10/2015)... ... October 10, 2015 , ... The Bank of America 500 NASCAR ... Saturday, October 10th, defending race winner, Kevin Harvick, will battle it out ... Earnhardt Jr., and all of the stars of the NASCAR Sprint Cup Series. ...
(Date:10/10/2015)... ... 2015 , ... Attending medical school and working on a ... children. Depending on the school, the exact details of the medical program differ; ... in a medical school must complete undergraduate classwork and requirements before moving into ...
(Date:10/10/2015)... ... October 10, 2015 , ... Well-known ... pleased to be recognized by The National Law Journal for inclusion in their ... law firms across the United States who obtained the largest awards for their ...
(Date:10/9/2015)... ... October 09, 2015 , ... Doctors on Liens has ... , to provide highly needed medical care to personal injury victims. When personal ... to diagnose, document and treat the variety of conditions ailing them. With the ...
Breaking Medicine News(10 mins):
... Report: , , Study highlights: , , Cardiac ... EMS personnel due to a number of external factors. , ... to give high-quality CPR and other resuscitation efforts before transporting ... guidelines for transporting cardiac arrest patients and determining when to ...
... Pioneering procedure aims to repair damaged cardiac muscle, surgeons say ... they,ve performed the first procedure in which a patient received ... attack damage. , The 39-year-old man is the first of ... a phase 1 clinical trial being conducted at Cedars-Sinai Heart ...
... obliged to bring unresponsive patient to hospital, study finds , ... heart attack that occurs outside of a hospital are slim, ... hospital anyway because a variety of factors keep them from ... In the United States, paramedics treat almost 300,000 people with ...
... don,t perform better than standard criteria, study finds , ... cardiac risk, such as inflammation-linked C-reactive protein (CRP), ... factors such as smoking, obesity, high cholesterol and physical ... markers have been touted as a better way of ...
... Physiological changes associated with the metabolic syndrome may play ... according to study results published in Cancer Epidemiology, ... Association for Cancer Research. The metabolic syndrome, ... factors including abdominal obesity, high blood glucose levels, impaired ...
... improperly , TUESDAY, June 30 (HealthDay News) -- ... dose for Tylenol and other pain medications should be ... recommended lowering the maximum dose of over-the-counter acetaminophen -- ... , Part of the problem, according to an FDA ...
Cached Medicine News:
(Date:10/9/2015)... REDWOOD CITY, Calif. , Oct. 9, 2015 ... a presentation will be made at the annual European Society ... th to October 14 th , 2015 at the ...  The annual EuSEM is the largest meeting of emergency medicine ... and 90 countries represented. Data from the previously ...
(Date:10/9/2015)... El ,JCA-Mauvernay Award 2015, se ha otorgado ... Junko Takita    --> El ,JCA-Mauvernay ... Yutaka Kondo y Junko Takita    ... ha otorgado a los doctores Yutaka Kondo ... compañía biofarmacéutica global con sede enSuiza, presentará el ,JCA-Mauvernay Award, el 10 de ...
(Date:10/8/2015)... , Oct. 8, 2015  Ardelyx, Inc. ... focused on gastrointestinal and cardio-renal diseases, today announced ... candidate, tenapanor, will be presented at the 2015 ... findings will include measures of sustained response in ... blind, placebo-controlled, randomized Phase 2 trial. The meeting ...
Breaking Medicine Technology:
... - Diatos SA, an international,biopharmaceutical company focusing ... anti-cancer drugs, today announced,that they presented data ... their,anti-cancer compound, DTS-201, at the 43rd Annual ... (ASCO) in Chicago, USA., DTS-201 is a ...
... June 04, 2007 /PRNewswire-FirstCall/ -- BSD,Medical Corp. announced ... Phase III clinical trial testing the benefit of ... annual,American Society of Clinical Oncology (ASCO) conference underway ... clinical study,which was conducted at nine major European ...
Cached Medicine Technology:
ArcticTemp Upright Freezer -20C. Thick wall insulation keeps your samples colder. Reversible door with magnetic gaskets. 2 shelves and a wire basket. Heavy duty compressor with 5 year warranty....
Undercounter Freezer -25C. White. Front opening freezer. 4 cubic ft capacity. Reversible door. Three slide-out drawers. Extra thick CFC insulation. Front lock. Front indicator lights. Attractive tabl...
... a portable system for routine pH, mV ... compensated pH results can be obtained when ... a 3-in-1 electrode. • Fast and easy ... automatic buffer recognition for five buffers (pH ...
... The F 265 is a highly accurate portable, ... and temperature measurements. Temperature compensated pH results can ... (ATC) or a 3-in-1 electrode. • This GLP/GMP ... to a printer or a computer. Up to ...
Medicine Products: